A. Cots Foraster
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Ginkgo biloba and Cashew Applications
- Restless Legs Syndrome Research
- Obsessive-Compulsive Spectrum Disorders
- Cerebral Palsy and Movement Disorders
- Dementia and Cognitive Impairment Research
- Erythropoietin and Anemia Treatment
- Dysphagia Assessment and Management
- Genetic Neurodegenerative Diseases
- Long-Term Effects of COVID-19
- Balance, Gait, and Falls Prevention
- RNA regulation and disease
- Folate and B Vitamins Research
- Pharmacological Effects and Toxicity Studies
- COVID-19 and Mental Health
- Diabetic Foot Ulcer Assessment and Management
- Child Nutrition and Feeding Issues
- Neurological and metabolic disorders
- Neuroscience and Neuropharmacology Research
Hospital Universitari de Girona Doctor Josep Trueta
2023
Institut d'Assistència Sanitària
2019-2022
Institut Català de la Salut
2021
Quality of life (QOL) plays an important role in independent living Parkinson's disease (PD) patients, being crucial to know what factors impact QoL throughout the course disease. Here we identified predictors impairment PD patients from a Spanish cohort. recruited 35 centers Spain COPPADIS cohort January 2016, November 2017, were followed up during 2 years. Health-related (HRQoL) and global (GQoL) assessed with 39-item Questionnaire (PDQ-39) EUROHIS-QOL 8-item index (EUROHIS-QOL8),...
IntroductionWe aimed to assess associations between multimodal neuroimaging measures of cholinergic basal forebrain (CBF) integrity and cognition in Parkinson's disease (PD) without dementia.MethodsThe study included a total 180 non-demented PD patients 45 healthy controls, who underwent structural MRI acquisitions standardized neurocognitive assessment through the PD-Cognitive Rating Scale (PD-CRS) within multicentric COPPADIS-2015 study. A subset 73 also had Diffusion Tensor Imaging (DTI)...
Abstract The study was aimed at analysing the frequency of impulse control disorders (ICDs) and compulsive behaviours (CBs) in patients with Parkinson’s disease (PD) subjects (CS) as well relationship between ICDs/CBs motor, nonmotor features dopaminergic treatment PD patients. Data came from COPPADIS-2015, an observational, descriptive, nationwide (Spain) study. We used validated Questionnaire for Impulsive-Compulsive Disorders Parkinson's Disease-Rating Scale (QUIP-RS) ICD/CB screening....
Reduced facial expression of emotions is a very frequent symptom Parkinson's disease (PD) and has been considered part the motor features disease. However, neural correlates hypomimia relationship between other non-motor symptoms PD are poorly understood.The clinical structural brain were studied. For this purpose, cross-sectional data from COPPADIS study database used. Age, duration, levodopa equivalent daily dose, Unified Disease Rating Scale III (UPDRS-III), severity apathy depression...
SARS-CoV-2 infection typically produces respiratory manifestations, although multiple neurological manifestations (seizures, stroke, etc.) have also been reported, it is postulated that (like most β-coronaviruses), has neurotropic potential. We present a case of Probable Parkinson’s Disease (PD) after SARSCoV-2 infection.